Beranda › Limfoma Sel-T › New York › New York City
Uji klinis Limfoma Sel-T di New York City, NY
13 studi untuk Limfoma Sel-T mencari peserta di lokasi sekitar New York City (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
Menerima pesertaFase 1
- Columbia University, New York
Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma
Menerima pesertaFase 2
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- Memorial Sloan Kettering Cancer Center, New York
- NYP/Weill Cornell Medical Center, New York
Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
Menerima pesertaFase 3
- Icahn School of Medicine at Mount Sinai, New York
- Memorial Sloan Kettering Cancer Center, New York
- Weill Cornell Medicine, New York
BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)
Menerima pesertaFase 1/2
- Memorial Sloan Kettering Cancer Center, New York
A Study of Ruxolitinib and Duvelisib in People With Lymphoma
Menerima pesertaFase 1
- Memorial Sloan Kettering Cancer Center, New York
CD4CAR for CD4+ Leukemia and Lymphoma
Menerima pesertaFase 1
- Albert Einstein Health Network, New York
A Phase 1/2 Study of STP938 (Dencatistat) for Adult Subjects With Relapsed/Refractory B-Cell and T-Cell Lymphomas
Menerima pesertaFase 1/2
- Memorial Sloan Kettering, New York
A Registry for People With T-cell Lymphoma
Menerima pesertaStudi observasional
- Weill Cornell Medical Center (Data Collection Only), New York
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Study of Mogamulizumab With DA-EPOCH or CHOEP in Patients With Aggressive T-cell Lymphoma
Menerima pesertaFase 2
- Icahn School of Medicine at Mount Sinai, New York
CD5-deleted Chimeric Antigen Receptor Cells (Senza5 CART5) for T Cell Non-Hodgkin Lymphoma (NHL)
Menerima pesertaFase 1
- Columbia University Irving Medical Center, New York
Tissue Repository: CTCL Collection Protocol
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Columbia University Irving Medical Center, New York
MB-105 in Patients With CD5 Positive T-cell Lymphoma
Menerima pesertaFase 2
- Memorial Sloan Kettering Cancer Center, New York
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
Menerima pesertaFase 1
- Children's Hospital New York-Presbyterian, New York
- Memorial Sloan Kettering Cancer Center, New York
Uji klinis Limfoma Sel-T di kota lain
- Philadelphia, PA10 studi
- Baldwin Park, CA9 studi
- Boston, MA9 studi
- Houston, TX8 studi
- Atlanta, GA8 studi
- Rochester, MN6 studi
- Columbus, OH6 studi
- Chicago, IL6 studi
- Seattle, WA6 studi
- New Haven, CT5 studi
- Miami, FL5 studi
- Scottsdale, AZ4 studi
Studi lain di New York City
- Kanker Payudara136 studi
- Kanker Paru Non-Sel Kecil121 studi
- Kanker (semua jenis)109 studi
- Kanker Prostat103 studi
- Kanker Metastatik93 studi
- Kanker Kolorektal78 studi
- Kanker Ovarium69 studi
- Kanker Paru60 studi
- Mieloma Multipel60 studi
- Kanker Pankreas60 studi
- Kanker Endometrium52 studi
- Leukemia Mieloid Akut51 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.